Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Pelu Tran

Ian Shakil

Augmedix, Inc.

VirtuSense Technologies provides AI-powered solutions designed for integration throughout the healthcare continuum, focusing on prevention and improving care touchpoints.

VirtuSense Technologies

CentralReach provides software solutions for Autism and Intellectual and Developmental Disabilities (IDD) care, according to self-described claims.

Metric
Company Name	Augmedix, Inc.	VirtuSense Technologies	CentralReach
Symbol	AUGX
MSH ID	COM:AUGMEDIX	AI:VIRTUSENSE	COM:CENTRALREACH
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Healthcare Information Services	Health Technology	Software for therapy and education
Country	US	US	US
Stage			Private Equity Round
Employee Count	1.43K
Website	augmedix.com	virtusense.ai	centralreach.com
LinkedIn
Founders

Metric
Market Cap	43.80M
Enterprise Value
Monthly Web Traffic		3.12K	4.67M
Web Traffic Growth		2.79	-0.19
Valuation
Raised Capital

Metric
Revenue	44.85M
Revenue (LTM)
Revenue (NTM)
Gross Profit	21.53M
EBITDA	-18.78M
Operating Income	-18.78M
Net Income	-19.17M
EPS	-0.00
Diluted EPS	-0.00
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.48
Operating Profit Margin	-0.41
EBITDA Margin	-0.42
Net Profit Margin	-0.42
Return on Equity	-1.78
Return on Assets	-0.29
Return on Capital Employed	-0.45

COM:AUGMEDIX

Augmedix, Inc.

Last Close

2.35

01/10 19:57

Market Cap

43.80M

Beta: -

Volume Today

23.00K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-9.63
P/B Ratio	268.54
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.50
EV Multiple	-2.68

Metric
Days Sales Outstanding	84.24
Days Payables Outstanding	30.69
Days Inventory Outstanding	0.00
Operating Cycle	74.79
Cash Conversion Cycle	58.47
Asset Turnover	0.96

Metric
Operating Cash Flow	-15.40M
Free Cash Flow	-15.40M
Cash Flow to Debt	-0.70
Operating Cash Flow/Sales	-0.22
Free Cash Flow Yield	-0.10

Metric
Cash & Equivalents	46.34M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization	0.68
Debt to Assets	0.71
Current Ratio	3.23
Quick Ratio	2.33

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue	0.27
SG&A to Revenue	0.44